Back

Co-morbidities and fragility are determinants of survival in patients with heart failure and mildly reduced ejection fraction

1 May 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Comorbodities co-morbidities (other) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Pedro Moliner

University Hospital of Bellvitge, Barcelona (Spain)

29 More presentations in this session

Presentation thumbnail
Doctor C. Saldarriaga (Medellin, CO)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor M. Anker (Berlin, DE)
Abstract
Presentation thumbnail
Doctor A. Gomes (Almada, PT)
Abstract
Presentation thumbnail
Doctor G. Fogarassy (Balatonfured, HU)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Comorbodities

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The impact of multimorbidity on mortality in heart failure with reduced ejection fraction (HFrEF): Which comorbidities matter most?
30 June 2021
thumbnail
Webinar
The HFA Journal Club: navigating frailty in heart failure treatment decisions - from trials to tailored care
1 October 2025
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
13 May 2024
thumbnail
Webinar
Unmet needs in HF: patients with LVEF equal or above 40%
12 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources